Lifecore Biomedical (LFCR) 10-K 2024 FY Annual report

Exhibit 23.2

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:

(1)Registration Statements (Form S-8 Nos. 333-234229 and 333-271175) pertaining to the Landec Corporation 2019 Stock Incentive Plan;

(2)Registration Statements (Form S-8 Nos. 333-193213 and 333-221039) pertaining to the Landec Corporation 2013 Stock Incentive Plan; and

(3)Registration Statement (Form S-1 No. 333-271176) pertaining to the registration of up to 12,667,486 shares of common stock, including (i) 627,746 issued and outstanding shares of common stock and (ii) 12,039,740 shares of common stock issuable upon the conversion of shares of Series A Convertible Preferred Stock

of our reports dated March 19, 2024, with respect to the consolidated financial statements of Lifecore Biomedical, Inc. included in this Annual Report (Form 10-K) of Lifecore Biomedical, Inc. for the year ended May 26, 2024.

/s/ Ernst & Young LLP

Minneapolis, Minnesota

August 26, 2024